Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5CEY

Crystal Structure of Fab 9H+3L, a putative precursor of the PGT121 family of potent HIV-1 antibodies

Summary for 5CEY
Entry DOI10.2210/pdb5cey/pdb
Related5CEX 5CEZ
DescriptorAntibody 9H+3L Fab light chain, Antibody 9H+3L Fab heavy chain, GLYCEROL, ... (6 entities in total)
Functional Keywordshiv-1, antibody, immune system
Biological sourceHomo sapiens
More
Total number of polymer chains4
Total formula weight98502.08
Authors
Wilson, I.A.,Garces, F. (deposition date: 2015-07-07, release date: 2015-12-23, Last modification date: 2024-11-20)
Primary citationGarces, F.,Lee, J.H.,de Val, N.,Torrents de la Pena, A.,Kong, L.,Puchades, C.,Hua, Y.,Stanfield, R.L.,Burton, D.R.,Moore, J.P.,Sanders, R.W.,Ward, A.B.,Wilson, I.A.
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.
Immunity, 43:1053-1063, 2015
Cited by
PubMed Abstract: The high-mannose patch on the HIV-1 envelope (Env) glycoprotein is the epicenter for binding of the potent broadly neutralizing PGT121 family of antibodies, but strategies for generating such antibodies by vaccination have not been defined. We generated structures of inferred antibody intermediates by X-ray crystallography and electron microscopy to elucidate the molecular events that occurred during evolution of this family. Binding analyses revealed that affinity maturation was primarily focused on avoiding, accommodating, or binding the N137 glycan. The overall antibody approach angle to Env was defined very early in the maturation process, yet some variation evolved in the PGT121 family branches that led to differences in glycan specificities in their respective epitopes. Furthermore, we determined a crystal structure of the recombinant BG505 SOSIP.664 HIV-1 trimer with a PGT121 family member at 3.0 Å that, in concert with these antibody intermediate structures, provides insights to advance design of HIV vaccine candidates.
PubMed: 26682982
DOI: 10.1016/j.immuni.2015.11.007
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.387 Å)
Structure validation

246905

PDB entries from 2025-12-31

PDB statisticsPDBj update infoContact PDBjnumon